Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects.

Trial Profile

Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2010

At a glance

  • Drugs Betahistine; Olanzapine
  • Indications Bipolar disorders; Schizophrenia; Weight gain
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors OBEcure
  • Most Recent Events

    • 10 Jun 2010 Betahistine reduces olanzapine-induced weight gain and sleepiness, according to results presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
    • 22 May 2010 Results were presented at the 163rd Annual Meeting of the American Psychiatric Association.
    • 15 Jun 2009 Preliminary results reported in a Obecure media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top